
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17370411
[patent_doc_number] => 20220025463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 17/495219
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/495219 | CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS | Oct 5, 2021 | Pending |
Array
(
[id] => 17370352
[patent_doc_number] => 20220025404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => COMPOSITIONS AND METHODS FOR MONITORING IN REAL-TIME CONSTRUCTION AND BIOENGINEERING OF MAMMALIAN SYNTHETIC CHROMOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/482307
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482307
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482307 | COMPOSITIONS AND METHODS FOR MONITORING IN REAL-TIME CONSTRUCTION AND BIOENGINEERING OF MAMMALIAN SYNTHETIC CHROMOSOMES | Sep 21, 2021 | Pending |
Array
(
[id] => 17490627
[patent_doc_number] => 11279919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Simultaneous multiplex genome editing in yeast
[patent_app_type] => utility
[patent_app_number] => 17/475392
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 38
[patent_no_of_words] => 32411
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 353
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/475392 | Simultaneous multiplex genome editing in yeast | Sep 14, 2021 | Issued |
Array
(
[id] => 18692961
[patent_doc_number] => 20230323323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHOD FOR PERFORMING GENE EDITING ON TARGET SITE IN CELL
[patent_app_type] => utility
[patent_app_number] => 18/025136
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025136
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025136 | METHOD FOR PERFORMING GENE EDITING ON TARGET SITE IN CELL | Sep 2, 2021 | Pending |
Array
(
[id] => 17299888
[patent_doc_number] => 20210395727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => SIMULTANEOUS MULTIPLEX GENOME EDITING IN YEAST
[patent_app_type] => utility
[patent_app_number] => 17/463956
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 308
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17463956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/463956 | Simultaneous multiplex genome editing in yeast | Aug 31, 2021 | Issued |
Array
(
[id] => 17482657
[patent_doc_number] => 20220090161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => DEVICES AND METHODS FOR PRODUCING NUCLEIC ACIDS AND PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/459053
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459053 | DEVICES AND METHODS FOR PRODUCING NUCLEIC ACIDS AND PROTEINS | Aug 26, 2021 | Pending |
Array
(
[id] => 17482566
[patent_doc_number] => 20220090070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS
[patent_app_type] => utility
[patent_app_number] => 17/398951
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/398951 | METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS | Aug 9, 2021 | Abandoned |
Array
(
[id] => 17974376
[patent_doc_number] => 11491213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues
[patent_app_type] => utility
[patent_app_number] => 17/305649
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 30
[patent_no_of_words] => 33992
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305649
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305649 | Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues | Jul 11, 2021 | Issued |
Array
(
[id] => 17385999
[patent_doc_number] => 20220033851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => mRNA, episomal and genomic integrated lentiviral and gammaretroviral vector expression of dimeric immunoglobulin A and polymeric immunoglobulin A to Enable Mucosal and Hematological Based Immunity/Protection via Gene Therapy for Allergens, viruses, HIV, bacteria, pneumonia, infections, pathology associated proteins, systemic pathologies, cancer, toxins and unnatural viruses. CAR engineered and non-CAR engineered immune cell expression of dimeric immunoglobulin A and polymeric immunoglobulin A.
[patent_app_type] => utility
[patent_app_number] => 17/368957
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368957
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368957 | mRNA, episomal and genomic integrated lentiviral and gammaretroviral vector expression of dimeric immunoglobulin A and polymeric immunoglobulin A to Enable Mucosal and Hematological Based Immunity/Protection via Gene Therapy for Allergens, viruses, HIV, bacteria, pneumonia, infections, pathology associated proteins, systemic pathologies, cancer, toxins and unnatural viruses. CAR engineered and non-CAR engineered immune cell expression of dimeric immunoglobulin A and polymeric immunoglobulin A. | Jul 6, 2021 | Pending |
Array
(
[id] => 17627271
[patent_doc_number] => 20220162286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/368698
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368698 | METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA | Jul 5, 2021 | Pending |
Array
(
[id] => 17156413
[patent_doc_number] => 20210317464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => INCREASED NUCLEIC-ACID GUIDED CELL EDITING IN YEAST
[patent_app_type] => utility
[patent_app_number] => 17/355081
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17355081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/355081 | INCREASED NUCLEIC-ACID GUIDED CELL EDITING IN YEAST | Jun 21, 2021 | Abandoned |
Array
(
[id] => 17421497
[patent_doc_number] => 11254942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Curing for recursive nucleic acid-guided cell editing
[patent_app_type] => utility
[patent_app_number] => 17/353282
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 51
[patent_no_of_words] => 36415
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353282
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353282 | Curing for recursive nucleic acid-guided cell editing | Jun 20, 2021 | Issued |
Array
(
[id] => 17990456
[patent_doc_number] => 20220356493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => DNA-BINDING PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/346020
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346020 | DNA-BINDING PROTEINS AND USES THEREOF | Jun 10, 2021 | Abandoned |
Array
(
[id] => 18739963
[patent_doc_number] => 20230348933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => TANDEM ANELLOVIRUS CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 18/009557
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009557 | TANDEM ANELLOVIRUS CONSTRUCTS | Jun 10, 2021 | Pending |
Array
(
[id] => 19076725
[patent_doc_number] => 11946077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleases
[patent_app_type] => utility
[patent_app_number] => 17/905617
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 30533
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905617 | OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleases | Jun 3, 2021 | Issued |
Array
(
[id] => 17769592
[patent_doc_number] => 11401521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
[patent_app_type] => utility
[patent_app_number] => 17/339617
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 30804
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339617 | Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias | Jun 3, 2021 | Issued |
Array
(
[id] => 17243748
[patent_doc_number] => 20210363491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => PRODUCTION OF INSULIN PRODUCING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/334933
[patent_app_country] => US
[patent_app_date] => 2021-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334933
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334933 | PRODUCTION OF INSULIN PRODUCING CELLS | May 30, 2021 | Pending |
Array
(
[id] => 17490648
[patent_doc_number] => 11279940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Iterative genome editing in microbes
[patent_app_type] => utility
[patent_app_number] => 17/332503
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 25
[patent_no_of_words] => 51249
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332503 | Iterative genome editing in microbes | May 26, 2021 | Issued |
Array
(
[id] => 17110158
[patent_doc_number] => 20210290755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => IMMUNOGENIC COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/330826
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/330826 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF | May 25, 2021 | Abandoned |
Array
(
[id] => 17911400
[patent_doc_number] => 20220313795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/329137
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/329137 | METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION | May 23, 2021 | Abandoned |